Your browser doesn't support javascript.
loading
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).
Ishii, Maki; Hirai, Ikuko; Tanese, Keiji; Fusumae, Takayuki; Nakamura, Yoshio; Fukuda, Keitaro; Uchi, Hiroshi; Kabashima, Kenji; Otsuka, Atsushi; Yokota, Kenji; Yamazaki, Naoya; Namikawa, Kenjiro; Fujimura, Taku; Takenouchi, Tatsuya; Yamamoto, Yuki; Nishiguchi, Mana; Sato, Yasunori; Amagai, Masayuki; Funakoshi, Takeru.
Afiliación
  • Ishii M; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Hirai I; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Tanese K; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Fusumae T; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Nakamura Y; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Fukuda K; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Uchi H; Department of Dermato-oncology, National Hospital Organization Kyushu Cancer Center.
  • Kabashima K; Department of Dermatology, Kyoto University Hospital.
  • Otsuka A; Department of Dermatology, Kyoto University Hospital.
  • Yokota K; Department of Dermatology, Nagoya University Hospital.
  • Yamazaki N; Department of Dermatologic oncology, National Cancer Center Hospital.
  • Namikawa K; Department of Dermatologic oncology, National Cancer Center Hospital.
  • Fujimura T; Department of Dermatology, Tohoku University Graduate School of Medicine.
  • Takenouchi T; Department of Dermatology, Niigata Cancer Center Hospital.
  • Yamamoto Y; Department of Dermatology, Wakayama Medical University.
  • Nishiguchi M; Department of Dermatology, Wakayama Medical University.
  • Sato Y; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
  • Amagai M; Department of Dermatology, Keio University School of Medicine, Tokyo.
  • Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo.
Medicine (Baltimore) ; 99(44): e22913, 2020 Oct 30.
Article en En | MEDLINE | ID: mdl-33126349
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma Basocelular / Carcinoma de Células Escamosas / Neoplasias de Anexos y Apéndices de Piel / Receptor de Muerte Celular Programada 1 / Nivolumab Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma Basocelular / Carcinoma de Células Escamosas / Neoplasias de Anexos y Apéndices de Piel / Receptor de Muerte Celular Programada 1 / Nivolumab Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos